SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891293-23-000011
Filing Date
2023-03-06
Accepted
2023-03-06 16:31:13
Documents
92
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ctic-20221231.htm   iXBRL 10-K 1718736
2 EX-4.4 a2022ex44descriptionofsecu.htm EX-4.4 12443
3 EX-23.1 a2022ex231accountingfirmco.htm EX-23.1 4059
4 EX-31.1 a2022ex311sect302certceo.htm EX-31.1 9974
5 EX-31.2 a2022ex312sect302certcfo.htm EX-31.2 10090
6 EX-32 a2022ex32sect906certceocfo.htm EX-32 7606
12 ctic-20221231_g1.jpg GRAPHIC 86389
  Complete submission text file 0000891293-23-000011.txt   8657631

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20221231.xsd EX-101.SCH 69916
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20221231_cal.xml EX-101.CAL 102471
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20221231_def.xml EX-101.DEF 330490
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20221231_lab.xml EX-101.LAB 786591
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20221231_pre.xml EX-101.PRE 512051
86 EXTRACTED XBRL INSTANCE DOCUMENT ctic-20221231_htm.xml XML 1159697
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28386 | Film No.: 23709341
SIC: 2834 Pharmaceutical Preparations